Kohjimoto Yoshiro | Primate Ltd

スポンサーリンク

概要

• Kohjimoto Yoshiroの詳細を見る
• 同名の論文著者
• Primate Ltdの論文著者

関連著者

• Egashira Kensuke

  Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University

• Sunagawa Kenji

  Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University

• 江頭 健輔

  九州大

• 江頭 健輔

  九州大学医学部循環器内科

• Sunagawa Kenji

  Department Of Cardiovascular Medicine Graduate School Of Medical Sciences Kyushu University

• Nakano Kaku

  Department of Cardiovascular Medicine, Kyushu University

• IHARA Yoshiko

  Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University

• Nakano Kaku

  Department Of Cardiovascular Medicine Kyushu University

• Ihara Yoshiko

  Department Of Cardiovascular Medicine Graduate School Of Medical Sciences Kyushu University

• Egashira Kensuke

  Department Of Cardiovascular Medicine Graduate School Of Medical Sciences Kyushu University

• Ohtani Kisho

  Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences

• Ohtani Kisyou

  Department Of Cardiovascular Medicine Graduate School Of Medicine Sciences Kyushu University

• Sunagawa Kenji

  Department Of Cardiovascular Dynamics National Cardiovascular Center

• 江頭 健輔

  九州大学大学院医学研究院

• Ihara Yoshiko

  Department Of Cardiovascular Medicine Graduate School Of Medicine Sciences Kyushu University

• Ohtani Kisho

  Department Of Cardiovascular Medicine Graduate School Of Medicine Sciences Kyushu University

• Hirouchi Yasuhiko

  Primate Ltd

• Kohjimoto Yoshiro

  Primate Ltd

• Kitajima Shunnichi

  Primate Ltd

• Ohtani Kisho

  Department Of Cardiovascular Medicine Graduate School Of Medical Sciences Kyushu University

• Sunagawa Kenji

  Department of Advanced Therapeutics for Cardiovascular Diseases, Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences

• KITAJIMA Shunichi

  Primate, Ltd.

• Kitajima Shunichi

  Primate Ltd.

もっと見る 閉じる

著作論文

• A Third-generation Long-acting Dihydropyridine Calcium Channel Blocker, Azelnidipine Attenuates Stent-associated Neointimal Formation in Hypercholesterolemic Non-human Primates (Restenosis after Angioplasty, Basic/Clinical 6 (IHD), The 69th Annual Scienti
• A Third-generation Long-acting Dihydropyridine Calcium Channel Blocker, Azelnidipine Attenuates Atherosclerosis Through Antioxidant Actions in Hypercholesterolemic Mice and Monkeys(Atherosclerosis, Basic 5 (IHD), The 69th Annual Scientific Meeting of the

スポンサーリンク